Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns

Daniel M. Caruso, Kevin N. Foster, Sigri A. Blome-Eberwein, John A. Twomey, David Herndon, Arnold Luterman, Paul Silverstein, Jeffrey R. Antimarino, Gregory J. Bauer

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

This prospective, randomized study compared protocols of care using either AQUACEL® Ag Hydrofiber® (ConvaTec, a Bristol-Myers Squibb company, Skillman, NJ) dressing with silver (n = 42) or silver sulfadiazine (n = 42) for up to 21 days in the management of partial-thickness burns covering 5% to 40% body surface area (BSA). AQUACEL® Ag dressing was associated with less pain and anxiety during dressing changes, less burning and stinging during wear, fewer dressing changes, less nursing time, and fewer procedural medications. Silver sulfadiazine was associated with greater flexibility and ease of movement. Adverse events, including infection, were comparable between treatment groups. The AQUACEL® Ag dressing protocol tended to have lower total treatment costs ($1040 vs. $1180) and a greater rate of re-epithelialization (73.8% vs 60.0%), resulting in cost-effectiveness per burn healed of $1,409.06 for AQUACEL® Ag dressing and $1,967.95 for silver sulfadiazine. A protocol of care with AQUACEL® Ag provided clinical and economic benefits compared with silver sulfadiazine in patients with partial-thickness burns.

Original languageEnglish (US)
Pages (from-to)298-309
Number of pages12
JournalJournal of Burn Care and Research
Volume27
Issue number3
DOIs
StatePublished - May 2006

Fingerprint

Silver Sulfadiazine
Bandages
Burns
Silver
Re-Epithelialization
Body Surface Area
Health Care Costs
Cost-Benefit Analysis
Clinical Studies
Nursing
Anxiety
Economics
Prospective Studies
Pain
Infection

ASJC Scopus subject areas

  • Emergency Medicine
  • Rehabilitation
  • Surgery

Cite this

Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns. / Caruso, Daniel M.; Foster, Kevin N.; Blome-Eberwein, Sigri A.; Twomey, John A.; Herndon, David; Luterman, Arnold; Silverstein, Paul; Antimarino, Jeffrey R.; Bauer, Gregory J.

In: Journal of Burn Care and Research, Vol. 27, No. 3, 05.2006, p. 298-309.

Research output: Contribution to journalArticle

Caruso, DM, Foster, KN, Blome-Eberwein, SA, Twomey, JA, Herndon, D, Luterman, A, Silverstein, P, Antimarino, JR & Bauer, GJ 2006, 'Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns', Journal of Burn Care and Research, vol. 27, no. 3, pp. 298-309. https://doi.org/10.1097/01.BCR.0000216741.21433.66
Caruso, Daniel M. ; Foster, Kevin N. ; Blome-Eberwein, Sigri A. ; Twomey, John A. ; Herndon, David ; Luterman, Arnold ; Silverstein, Paul ; Antimarino, Jeffrey R. ; Bauer, Gregory J. / Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns. In: Journal of Burn Care and Research. 2006 ; Vol. 27, No. 3. pp. 298-309.
@article{63b09f0f34c143e681779de1b6afad1c,
title = "Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns",
abstract = "This prospective, randomized study compared protocols of care using either AQUACEL{\circledR} Ag Hydrofiber{\circledR} (ConvaTec, a Bristol-Myers Squibb company, Skillman, NJ) dressing with silver (n = 42) or silver sulfadiazine (n = 42) for up to 21 days in the management of partial-thickness burns covering 5{\%} to 40{\%} body surface area (BSA). AQUACEL{\circledR} Ag dressing was associated with less pain and anxiety during dressing changes, less burning and stinging during wear, fewer dressing changes, less nursing time, and fewer procedural medications. Silver sulfadiazine was associated with greater flexibility and ease of movement. Adverse events, including infection, were comparable between treatment groups. The AQUACEL{\circledR} Ag dressing protocol tended to have lower total treatment costs ($1040 vs. $1180) and a greater rate of re-epithelialization (73.8{\%} vs 60.0{\%}), resulting in cost-effectiveness per burn healed of $1,409.06 for AQUACEL{\circledR} Ag dressing and $1,967.95 for silver sulfadiazine. A protocol of care with AQUACEL{\circledR} Ag provided clinical and economic benefits compared with silver sulfadiazine in patients with partial-thickness burns.",
author = "Caruso, {Daniel M.} and Foster, {Kevin N.} and Blome-Eberwein, {Sigri A.} and Twomey, {John A.} and David Herndon and Arnold Luterman and Paul Silverstein and Antimarino, {Jeffrey R.} and Bauer, {Gregory J.}",
year = "2006",
month = "5",
doi = "10.1097/01.BCR.0000216741.21433.66",
language = "English (US)",
volume = "27",
pages = "298--309",
journal = "Journal of Burn Care and Research",
issn = "1559-047X",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Randomized clinical study of hydrofiber dressing with silver or silver sulfadiazine in the management of partial-thickness burns

AU - Caruso, Daniel M.

AU - Foster, Kevin N.

AU - Blome-Eberwein, Sigri A.

AU - Twomey, John A.

AU - Herndon, David

AU - Luterman, Arnold

AU - Silverstein, Paul

AU - Antimarino, Jeffrey R.

AU - Bauer, Gregory J.

PY - 2006/5

Y1 - 2006/5

N2 - This prospective, randomized study compared protocols of care using either AQUACEL® Ag Hydrofiber® (ConvaTec, a Bristol-Myers Squibb company, Skillman, NJ) dressing with silver (n = 42) or silver sulfadiazine (n = 42) for up to 21 days in the management of partial-thickness burns covering 5% to 40% body surface area (BSA). AQUACEL® Ag dressing was associated with less pain and anxiety during dressing changes, less burning and stinging during wear, fewer dressing changes, less nursing time, and fewer procedural medications. Silver sulfadiazine was associated with greater flexibility and ease of movement. Adverse events, including infection, were comparable between treatment groups. The AQUACEL® Ag dressing protocol tended to have lower total treatment costs ($1040 vs. $1180) and a greater rate of re-epithelialization (73.8% vs 60.0%), resulting in cost-effectiveness per burn healed of $1,409.06 for AQUACEL® Ag dressing and $1,967.95 for silver sulfadiazine. A protocol of care with AQUACEL® Ag provided clinical and economic benefits compared with silver sulfadiazine in patients with partial-thickness burns.

AB - This prospective, randomized study compared protocols of care using either AQUACEL® Ag Hydrofiber® (ConvaTec, a Bristol-Myers Squibb company, Skillman, NJ) dressing with silver (n = 42) or silver sulfadiazine (n = 42) for up to 21 days in the management of partial-thickness burns covering 5% to 40% body surface area (BSA). AQUACEL® Ag dressing was associated with less pain and anxiety during dressing changes, less burning and stinging during wear, fewer dressing changes, less nursing time, and fewer procedural medications. Silver sulfadiazine was associated with greater flexibility and ease of movement. Adverse events, including infection, were comparable between treatment groups. The AQUACEL® Ag dressing protocol tended to have lower total treatment costs ($1040 vs. $1180) and a greater rate of re-epithelialization (73.8% vs 60.0%), resulting in cost-effectiveness per burn healed of $1,409.06 for AQUACEL® Ag dressing and $1,967.95 for silver sulfadiazine. A protocol of care with AQUACEL® Ag provided clinical and economic benefits compared with silver sulfadiazine in patients with partial-thickness burns.

UR - http://www.scopus.com/inward/record.url?scp=33745645696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745645696&partnerID=8YFLogxK

U2 - 10.1097/01.BCR.0000216741.21433.66

DO - 10.1097/01.BCR.0000216741.21433.66

M3 - Article

C2 - 16679897

AN - SCOPUS:33745645696

VL - 27

SP - 298

EP - 309

JO - Journal of Burn Care and Research

JF - Journal of Burn Care and Research

SN - 1559-047X

IS - 3

ER -